Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 3265
TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395790BDBM395790(US10308654, Example 18)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395791BDBM395791(US10308654, Example 19)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395792BDBM395792(US10308654, Example 20)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395788BDBM395788(US10308654, Example 16)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395789BDBM395789(US10308654, Example 17)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395786BDBM395786(US10308654, Example 14)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395787BDBM395787(US10308654, Example 15)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395784BDBM395784(US10308654, Example 12)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395785BDBM395785(US10308654, Example 13)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395799BDBM395799(US10308654, Example 27)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395801BDBM395801(US10308654, Example 29)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395797BDBM395797(US10308654, Example 25)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395798BDBM395798(US10308654, Example 26)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395795BDBM395795(US10308654, Example 23)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395796BDBM395796(US10308654, Example 24)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395793BDBM395793(US10308654, Example 21)
Affinity DataIC50: 10nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395800BDBM395800(US10308654, Example 28)
Affinity DataIC50: 55nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase 4/G1/S-specific cyclin-D1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395794BDBM395794(US10308654, Example 22)
Affinity DataIC50: 55nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395790BDBM395790(US10308654, Example 18)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395788BDBM395788(US10308654, Example 16)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395789BDBM395789(US10308654, Example 17)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395786BDBM395786(US10308654, Example 14)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395787BDBM395787(US10308654, Example 15)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395801BDBM395801(US10308654, Example 29)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395785BDBM395785(US10308654, Example 13)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395799BDBM395799(US10308654, Example 27)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395797BDBM395797(US10308654, Example 25)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395798BDBM395798(US10308654, Example 26)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395795BDBM395795(US10308654, Example 23)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395796BDBM395796(US10308654, Example 24)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395792BDBM395792(US10308654, Example 20)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Changzhou Longthera Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 395793BDBM395793(US10308654, Example 21)
Affinity DataIC50: 550nMAssay Description:The test compound was dissolved in dimethyl sulfoxide and the solution was diluted to each concentration gradient with a buffer (50 mM HEPES, 10 mM M...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
US Patent